Abnormal red blood cell ion transport and hypertension. The People's Gas Company study
- PMID: 6840823
- DOI: 10.1161/01.hyp.5.3.363
Abnormal red blood cell ion transport and hypertension. The People's Gas Company study
Abstract
A population-based survey of 134 white men, recruited from the Chicago People's Gas Company labor force, was carried out to examine the association between sodium-lithium (Na-Li) countertransport and hypertension. Of the 134 participants in this industry-sponsored periodic health examination, 64 were normotensive and 70 were either taking antihypertensive medications or had a systolic pressure greater than or equal to 140 or a diastolic pressure greater than or equal to 90 mm Hg. The hypertensives were older and more overweight. Countertransport was significantly higher in hypertensives than in normotensives. Among the three subgroups of hypertensives--untreated, borderline (140/90 to 160/95 mm Hg), untreated definite (over 160/95 mm Hg), and treated--an increase in countertransport was consistently observed, significant for the latter two groups. The relationship between countertransport and hypertension was independent of overweight, with countertransport being significantly related to both blood pressure and overweight. Altered ion transport may play an important role in the etiology and/or pathophysiology of hypertension.
Similar articles
-
Sodium-lithium countertransport in ambulatory hypertensive and normotensive patients.Hypertension. 1987 Jan;9(1):24-34. doi: 10.1161/01.hyp.9.1.24. Hypertension. 1987. PMID: 2432010
-
Red cell lithium-sodium countertransport and sodium-potassium cotransport in patients with essential hypertension.Hypertension. 1982 Nov-Dec;4(6):795-804. doi: 10.1161/01.hyp.4.6.795. Hypertension. 1982. PMID: 7141606
-
Peripheral resistance and red cell Li-Na countertransport in borderline hypertensives.Life Sci. 1983 Apr 4;32(14):1621-7. doi: 10.1016/0024-3205(83)90869-x. Life Sci. 1983. PMID: 6835006
-
Lithium-sodium countertransport: physiological moorings for red cell transport disorders in hypertension.J Cardiovasc Pharmacol. 1986;8 Suppl 5:S76-81. doi: 10.1097/00005344-198608005-00015. J Cardiovasc Pharmacol. 1986. PMID: 2427890 Review.
-
Genetic and epidemiological studies on electrolyte transport systems in hypertension.Clin Physiol Biochem. 1988;6(3-4):136-49. Clin Physiol Biochem. 1988. PMID: 3060295 Review.
Cited by
-
Changes in sodium-lithium countertransport correlate with changes in triglyceride levels and body mass index over 2 1/2 years of follow-up in Utah.Cardiovasc Drugs Ther. 1990 Mar;4 Suppl 2:357-62. doi: 10.1007/BF02603176. Cardiovasc Drugs Ther. 1990. PMID: 2271398
-
Metabolic effects of long-term therapy with muzolimine and chlorthalidone in hypertension.Eur J Clin Pharmacol. 1987;33(5):515-7. doi: 10.1007/BF00544246. Eur J Clin Pharmacol. 1987. PMID: 3428346 Clinical Trial.
-
Na+-Li+ countertransport and electrolyte composition in erythrocytes of patients with essential hypertension before and after antihypertensive treatment.Klin Wochenschr. 1986 Oct 31;64(21):1101-5. doi: 10.1007/BF01726869. Klin Wochenschr. 1986. PMID: 3807255
-
Hyperinsulinemia. A link between hypertension obesity and glucose intolerance.J Clin Invest. 1985 Mar;75(3):809-17. doi: 10.1172/JCI111776. J Clin Invest. 1985. PMID: 3884667 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical